Health Economics and Outcomes Research (HEOR)

    Health-economics-outcomes-research-analytics

    Health economics and outcomes research (HEOR)

    Real-world evidence (RWE)-based treatment publications to meet the growing value-based pricing, market access, and reimbursement requirements.

    HEOR publications to guide managed care decisions

    Increased focus on value-based pricing means that life sciences companies need to embrace the “volume-to-value” shift in their organizational DNA. The pressure to systematically demonstrate RWE-based value as medical publications is more significant than ever before – critical to ensuring desired pricing, coverage, and reimbursement throughout the product’s lifecycle.

    A sound HEOR capability is crucial for publication planning to guide decision-makers on meeting global patient-access demands.

    Benefits

    HEOR-capabilities-icon1

    Fully customizable and transparent cost-effectiveness model for a pre-launch drug.

    HEOR-capabilities-icon2

    A budget impact model to assess the financial consequences of drug adoption from payers’ perspective.

    HEOR-capabilities-icon3

    Estimated RWE-based disease prevalence for granular patient segments using an optimization algorithm.

    Meeting the global HEOR demands with strategic partnership and analytics

    A growing need for HEOR
    • Increasing value-based assessments
    • Disparate evidence generation and poor management
    • Increasing RWE consumers across commercial functions
    • Increasing pricing pressure-driven value demonstration need
    Axtria’s HEOR capabilities
    • Evidence publications management across the product life cycle
    • Robust data management expertise across real-world data sets
    • Advanced health economics publications and evaluation modeling skills
    • Clinical expertise and value assessment-driven budget impact models

    High-impact solutions offered

    Patient-level simulation

    Patient-level simulation

    Test and analyze complex treatment outcomes on various types of patients with our patient-level simulations, supported with real-world and clinical trials data.

    Cost-effectiveness models

    Cost-effectiveness models

    Ensure cost-effectiveness to maximize the chances of drug approval with our customized and analytically rigorous models. These models are transparent and adaptable for global stakeholders.

    Clinical trial simulations

    Clinical trial simulations

    Make informed decisions for clinical trial design with Axtria’s trial simulations. Ensure cost-effective analyses and reduced iterations across varying scenarios for continued product benefits.

    The burden of disease analysis

    The burden of disease analysis

    Get detailed insights into the cost, morbidity, mortality, and unmet needs associated with multiple treatment options to maximize patient well-being and cost-effectiveness.

    Real-world data experience

    Real-world data experience

    Experience RWE-based insights, using real-world and anonymized patient-level data to make educated decisions on various treatment options and their actual outcomes.

    Managed markets and HEOR analytics

    Managed markets and HEOR analytics

    Unveil market complexities with Axtria’s deep domain and strategy consulting expertise in managed markets and hands-on experience with traditional and emerging datasets in this space.


    Differentiated modeling studies

    What-makes-axtrias-HEOR-modeling-studies-unique-GreenBG-3
    HEOR-modeling-icon1-2 HEOR-modeling-icon1-active-3

    Domain knowledge

    HEOR-modeling-icon2-2 HEOR-modeling-icon2-active-3

    Technical expertise

    HEOR-modeling-icon3-3 HEOR-modeling-icon3-active-3

    Customizability and agility

    HEOR-modeling-icon4-2 HEOR-modeling-icon4-active-4

    Innovation

    • Deep understanding and experience of diverse data sets
    • Deep therapeutic area expertise
    • A team of experienced modelers, statisticians, and academic writers
    • Extensive HEOR/RWE modeling experience
    • Proactive engagement with key stakeholders to design easily scalable and adaptable models
    • Statistically robust and clinically sound models
    • Design solutions that can withstand scrutiny during evidence dissemination
    • Continuous efforts towards implementing disruptive modeling approaches

    Axtria research hub

    White Paper

    The Evolution and Future of Integrated Evidence Planning

    Webinar

    Evidence Generation: Evolution and Future of Integrated Evidence Planning

    Report

    HEOR Value Demonstration And Evidence Generation Challenges

    Customer success stories

    Case Study

    Automated Email Campaigns Support The Patient Assistance Journey For Enhanced Treatment Outcomes

    Case Study

    Patient Flow Analysis For A Global Oncology Leader

    Case Study

    Predictive Analytics For A Healthcare Company To Improve Patient Care